Skip to main content

Together we are beating cancer

Donate now

Chemotherapy

Showing 12 out of 185 results
Cancer Research UK logo

Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at the American Society of Clinical Oncology (ASCO) conference, today. Changing the order that chemotherapy drugs are given to breast cancer patients before surgery makes treatment much more effective, according to trial results presented at the American Society of Clinical Oncology (ASCO) conference, today.

by Cancer Research UK | News | 29 May 2009

29 May 2009

Cancer Research UK logo

Cancer Research UK scientists led an international team of investigators who have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment called gemcitabine, according to a study published in Science today. Cancer Research UK scientists led an international team of investigators who have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment called gemcitabine, according to a study published in Science today.

by Cancer Research UK | News | 21 May 2009

21 May 2009

Cancer Research UK logo

A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences* today (Monday). A pattern of genetic defects in tumours could indicate whether ovarian cancer patients will respond to common chemotherapy drugs before treatment starts, reveals a Cancer Research UK study published in the Proceedings of the National Academy of Sciences* today (Monday).

by Cancer Research UK | News | 4 May 2009

4 May 2009

Cancer Research UK logo

More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, according to research published in the Journal of Clinical Oncology*. More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, according to research published in the Journal of Clinical Oncology*.

by Cancer Research UK | News | 6 March 2009

6 March 2009

Cancer Research UK logo
  • Health & Medicine
  • Science & Technology

Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**. Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**.

by Cancer Research UK | News | 6 February 2009

6 February 2009

Cancer Research UK logo

The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer* today. The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer* today.

by British Journal of Cancer | News | 21 January 2009

21 January 2009

Cancer Research UK logo

SCIENTISTS have revealed for the first time that cancer cells can reverse a process which irrevocably commits normal cells to die, in a study published in the British Journal of Cancer,*. SCIENTISTS have revealed for the first time that cancer cells can reverse a process which irrevocably commits normal cells to die, in a study published in the British Journal of Cancer,*.

by Cancer Research UK | News | 5 January 2009

5 January 2009

Cancer Research UK logo

CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who wonїt benefit from commonly used chemotherapy drugs. CANCER RESEARCH UK scientists have found that a test, already used in breast cancer diagnosis, can also predict who will and who wonїt benefit from commonly used chemotherapy drugs.

by Cancer Research UK | News | 12 December 2008

12 December 2008

Cancer Research UK logo

A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday). A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday).

by Cancer Research UK | News | 6 October 2008

6 October 2008

Cancer Research UK logo

Scientists have discovered a better way to identify and treat a commonly misdiagnosed cancer affecting young adults and teenagers, a study published in Blood* reveals today (Monday). Scientists have discovered a better way to identify and treat a commonly misdiagnosed cancer affecting young adults and teenagers, a study published in Blood* reveals today (Monday).

by Cancer Research UK | News | 8 September 2008

8 September 2008